Elgethun Capital Management Sab Biotherapeutics, Inc. Transaction History

Elgethun Capital Management

  • $361 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
BUY
$0.38 - $1.09 $1,099 - $3,154
2,894 Added 41.1%
9,935 $8,000
Q1 2023

May 11, 2023
SELL
$0.42 - $0.75 $3,257 - $5,816
-7,755 Reduced 52.41%
7,041 $3,000
Q4 2022

Feb 10, 2023
BUY
$0.54 - $9.8 $810 - $14,700
1,500 Added 11.28%
14,796 $8,000
Q2 2022

Aug 12, 2022
BUY
$1.11 - $3.46 $14,758 - $46,004
13,296 New
13,296 $18,000

Others Institutions Holding SABS

# of Institutions
3
Shares Held
529K
Call Options Held
0
Put Options Held
0
View Full List

About SAB Biotherapeutics, Inc.

SABS Quotes by TradingView
  • Ticker SABS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,030,900
  • Market Cap $111M
  • Description
  • SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases ...
More about SABS
Track This Portfolio

Track Elgethun Capital Management Portfolio

Follow Elgethun Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elgethun Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Elgethun Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email